AVAC analysis
The US Department of State abruptly announced plans to terminate, by May 30, 2026, the Global Health Supply Chain–Procurement and Supply Management (GHSC-PSM) mechanism, which has been implemented by a consortia led by Chemonics and which is responsible for end-to-end procurement and delivery of HIV, TB and malaria commodities. In March, State Department Senior Official Jeremy Lewin, decided to extend Chemonics’ contract until 2027. This reversal of that decision comes without a clear transition plan, posing significant risk of medication stockouts and disruption in getting diagnostics and medications to communities. There has been some discussion of a future shift toward the wambo.org platform used by the Global Fund, which primarily serves as a pooled procurement mechanism, and hasn’t historically provided logistics support, such as warehouses and last-mile distribution. Two hundred and fifty civil society organizations signed on to a letter to the US Secretary of State calling for immediate reversal of this decision and retaining the earlier decision made by Lewin.
IMPLICATIONS: Without proper planning and capacity, an abrupt transition from GHSC-PSM to wambo.org or other platforms risks severe disruptions to HIV, TB and malaria care. Advocates stress that any transition must be deliberate, transparent and centered on continuity of care, with sufficient time to vet new partners to avoid the waste, fraud and abuse that can plague procurement processes. The priority now is not just opposing the timeline, but identifying and securing the components of a responsive, resilient supply system and ensuring that any new mechanism can meet those standards before critical systems are dismantled.
Further coverage:
- Reuters: Exclusive: US upends global supply program for malaria and HIV amid warnings of gaps
- To End a Plague…Again Substack: Exclusive: Country deadlines for emergency closeout of US Global Health Supply Chain
- Alain Casseus Substack: When the supply chain is the system
AVAC publishes a weekly Global Health Watch, a curated digest of key developments in global health. Access this week’s issue (10 April) here.
Source : AVAC
Related HIV and Co-Infections News
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
KFF: US: Global health funding in the FY 2027 President’s budget request
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.